Selective Uptake Into Drug Resistant Mammalian Cancer by Cell Penetrating Peptide-Mediated Delivery

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Research

Background:

• Multidrug resistance (MDR) in cancer therapy is a significant challenge, stemming from factors like altered cell surface receptors, metabolic changes, and drug efflux mechanisms.
• Nanoparticles offer a promising solution as drug delivery vehicles, particularly for nucleic acid-based agents, providing protection and enhanced delivery.
• Cell penetrating peptides (CPPs), also known as protein transduction domains, can facilitate cellular uptake of therapeutic payloads.

Purpose of the Study:

• To investigate the cellular uptake profiles of various cell penetrating peptides (CPPs) functionalized onto fluorescent quantum dots.
• To assess the efficacy of CPP-functionalized nanoparticles in overcoming multidrug resistance (MDR) in different cancer cell lines.
• To explore the potential of these nanoplatforms for future clinical applications in treating drug-resistant cancers.

Main Methods:

• Eight distinct cell penetrating peptides (CAAKA, HSV1-VP22, HIV-TAT, HIV-gp41, Ku-70, hCT(9-32), integrin-β3, and K-FGF) were synthesized and conjugated to fluorescent quantum dots.
• Cellular uptake of these CPP-functionalized quantum dots was evaluated in various cancer cell lines, including drug-sensitive and drug-resistant melanoma, mesothelioma, and glioma models.
• Quantitative analysis of CPP uptake was performed to determine variations based on cell type and drug resistance status.

Main Results:

• Significant variations in cellular uptake were observed among the eight cell penetrating peptides across different cancer cell lines.
• Uptake efficiency of CPP-functionalized nanoparticles was found to be dependent on the drug resistance status of the cancer cells.
• Differences in uptake profiles suggest a correlation with cell type-specific surface markers and drug resistance mechanisms.

Conclusions:

• Cell penetrating peptide choice critically influences nanoparticle uptake in multidrug-resistant (MDR) cancer cells.
• Understanding CPP-cell surface interactions is key to designing effective nanodelivery systems for overcoming MDR.
• This study provides valuable insights for developing targeted nanoplatforms to enhance therapeutic delivery in challenging drug-resistant cancer models.